CRISPR FokI Dead Cas9 System: Principles and Applications in Genome Engineering

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• The Clustered Regularly Interspersed Short Palindromic Repeats (CRISPR) associated endonuclease (Cas9) system is a powerful gene-editing tool.
• Off-target mutations limit the therapeutic applications of standard CRISPR/Cas9 systems.
• Zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) are alternative, more complex gene-editing tools.

Purpose of the Study:

• To review the advantages of published variants of the CRISPR-FokI dead Cas9 (fdCas9) system.
• To discuss the current applications of fdCas9 in genome engineering.
• To highlight strategies for enhancing CRISPR/Cas9 specificity.

Main Methods:

• The fdCas9 system links a FokI endonuclease catalytic domain to an inactive Cas9 protein.
• Requires a pair of guide sgRNAs binding to sense and antisense DNA strands in a PAM-out orientation.
• FokI domain dimerization induces DNA double-strand breaks, activating repair pathways for genomic editing.

Main Results:

• Engineered fdCas9 variants demonstrate promising gene-editing activities in human cells.
• fdCas9 offers improved specificity compared to other gene-editing platforms.
• The system relies on specific guide RNA pairing and FokI dimerization for targeted DNA cleavage.

Conclusions:

• The fdCas9 system represents an advanced strategy for highly specific CRISPR/Cas9-mediated genome editing.
• fdCas9 variants show significant potential for therapeutic applications due to enhanced precision.
• Continued development of fdCas9 variants is crucial for expanding its role in genome engineering.